In vitro and in vivo evaluation of lyophilized bovine bone biocompatibility

Clinics

Volumn 63, Issue 6, 2008, Pages 801-806

  Galia, Carlos Roberto ^a   Macedo, Carlos Alberto ^a   Rosito, Ricardo ^a   De Mello, Tielle Muller ^b   Camargo, Lourdes Maria Araújo Quaresma ^c   Moreira, Luis Fernando ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Bone transplantation; Freeze drying; Materials testing; Surgery; Toxicity tests

Indexed keywords

ANIMAL; ARTICLE; BONE PROSTHESIS; CATTLE; CELL LINE; DRUG EFFECT; FREEZE DRYING; MALE; MATERIALS TESTING; METHODOLOGY; MOUSE; TOXICITY TESTING;

ANIMALS; BONE SUBSTITUTES; CATTLE; CELL LINE; FREEZE DRYING; MALE; MATERIALS TESTING; MICE; TOXICITY TESTS;

EID: 57349150257     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322008000600016     Document Type: Article

References (36)

1. Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am. 2002;84-A:454-64.
2. Laurencin CT. Bone Graft Substitute Materials. Bridgeport: ASTM International; 2003.
3. Seiler JG 3rd, Johnson J. Iliac crest autogenous bone grafting: donor site complications. J South Orthop Assoc. 2000;9:91-7.
4. Lind M, Krarup N, Mikkelsen S, Horlyck E. Exchange impaction allografting for femoral revision hip arthroplasty: results in 87 cases after 3.6 years' follow-up. J Arthroplasty. 2002;17:158-64.
5. Palmer SH, Gibbons CL, Athanasou NA. The pathology of bone allograft. J Bone Joint Surg Br. 1999;81:333-5.
6. Sugihara S, van Ginkel AD, Jiya TU, van Royen BJ, van Diest PJ, Wuisman PI. Histopathology of retrieved allografts of the femoral head. J Bone Joint Surg Br. 1999;81:336-41.
7. Taga EM. Biomateriais para uso em clínica medico- odontológica. Rev Bras Cir Implant. 1996;3:59-69.
8. Morax S, Hurbli T, Smida R. [Bovine heterologous bone graft in orbital surgery]. Ann Chir Plast Esthet. 1993;38:445-50.
9. Galia CR. Enxertos ósseos liofilizados impactados humano e bovino em revisão de artroplastia total de quadril [dissertation]. Porto Alegre (RS): Universidade Federal do Rio Grande do Sul; 2004.
10. Meyer S, Floerkemeier T, Windhagen H. Histological osseointegration of Tutobone ((R)): first results in human. Arch Orthop Trauma Surg. 2008;128:539-44.
11. Williams D. Revisiting the definition of biocompatibility. Med Device Technol. 2003;14:10-3.
12. Nuss KM, Auer JA, Boos A, von Rechenberg B. An animal model in sheep for biocompatibility testing of biomaterials in cancellous bones. BMC Musculoskelet Disord. 2006;7:67.
13. Pearce AI, Richards RG, Milz S, Schneider E, Pearce SG. Animal models for implant biomaterial research in bone: a review. Eur Cell Mater. 2007;13:1-10.
14. ISO - International Organization for Standardization. ISO 10993-11: Biological evaluation of medical devices. Designing Subchronic and Chronic Systemic Toxicity Tests. http://marketplace.aami.org/eseries/scriptcontent/docs/ Preview%20Files%5C10993110610preview.pdf. Access: 03/04/2008.
15. Wallin RF. Biocompatibility: A quarter century of progress. MDDI. 2004:146-51.
16. Kakiuchi M, Ono K, Nishimura A, Shiokawa H. Preparation of bank bone using defatting, freeze-drying and sterilisation with ethylene oxide gas. Part 1. Experimental evaluation of its efficacy and safety. Int Orthop. 1996;20:142-6.
17. Mbithi JN, Springthorpe VS, Sattar SA. Chemical disinfection of hepatitis A virus on environmental surfaces. Appl Environ Microbiol. 1990;56:3601-4.
18. Aranda-Anzaldo A, Viza D, Busnel RG. Chemical inactivation of human immunodeficiency virus in vitro. J Virol Methods. 1992;37:71-81.
19. Taylor D. Inactivation of the BSE agent. C R Biol. 2002;325:75-6.
20. Chappard D, Fressonnet C, Genty C, Baslé MF, Rebel A. Fat in bone xenografts: importance of the purification procedures on cleanliness, wettability and biocompatibility. Biomaterials. 1993;14:507-12.
21. ISO - International Organization for Standardization. ISO 10993-5: Biological evaluation of medical devices, Part 5: tests for in vitro cytotoxicity. http://marketplace.aami.org/eseries/scriptcontent/docs/ Preview%20Files/10993-5preview.pdf. Access: 03/10/2008.
22. U.S. Pharmacopeia XXVIII. The United States Pharmacopoeia. The National Formulary. 28th ed. Rockville: United States Pharmacopeial Convention; 2005.
23. U.S. Pharmacopeia XXIII. The United States Pharmacopoeia. The National Formulary. 28th ed. Rockville: United States Pharmacopeial Convention; 2005.
24. U.S. Pharmacopeia XXVIII/NF. The United States Pharmacopoeia. The National Formulary. 28th ed. Rockville: United States Pharmacopeial Convention; 2005.
25. Giovani AM, Croci AT, Oliveira CR, Filippi RZ, Santos LA, Maragni GG, et al. Comparative study of cryopreserved bone tissue and tissue preserved in a 98% glycerol solution. Clinics. 2006;61:565-70
26. Wenz B, Oesch B, Horst M. Analysis of the risk of transmitting bovine spongiform encephalopathy through bone grafts derived from bovine bone. 2001;22:1599-606.
27. Sendelbach LE, Wallin RF. A Practical Guide to ISO 10993-11: Designing Subchronic and Chronic Systemic Toxicity Tests. MDDI. 1998;20:102-5.
28. Wallin RF, Arscott EF. A Practical Guide to ISO 10993-5: Cytotoxicity. MDDI. 1998;20:96-8.
29. Eveson JW. Animal models of intra-oral chemical carcinogenesis: a review. J Oral Pathol. 1981;10:129-46.
30. Anand VP. Biocompatibility Safety Assessment of Medical Devices: FDA/ISO and Japanese Guidelines. MDDI. 2000;22:206-9.
31. Lambert RJ. A model for the thermal inactivation of micro-organisms. J Appl Microbiol. 2003;95:500-7.
32. Bryans T, Alexander K. Using recovery tests to assess bioburden procedures. MDDI. 2002;10:73-9.
33. American National Standards Institute - ANSI. ANSI/AAMI/ISO 11137/2006 Sterilization of Healthcare Products: Requirements for Validation and Routine Control - Radiation Sterilization. http://www.berkshire.com/ansi.shtml.
34. Fideler BM, Vangsness CT Jr, Lu B, Orlando C, Moore T. Gamma irradiation: effects on biomechanical properties of human bone-patellar tendon-bone allografts. Am J Sports Med. 1995;23:643-6.
35. Moreau MF, Gallois Y, Baslé MF, Chappard D. Gamma irradiation of human bone allografts alters medullary lipids and releases toxic compounds for osteoblast-like cells. 2000;21:369-76.
36. Nguyen H, Morgan DA, Forwood MR. Sterilization of allograft bone: effects of gamma irradiation on allograft biology and biomechanics. Cell Tissue Bank. 2007;8:93-105.